Read more at MarketWatch.
CureVac’s stock soars on GSK’s $1.56 billion deal for its COVID-19 and flu vaccines
Date: |
Sort by
Filter
Date
-
The Wall Street Journal - Business
GSK, CureVac Expand Licensing Agreement
GSK struck a deal to buy the rights to CureVac’s Covid-19 and flu vaccines for up to $1.56 billion, in a bid to regain ground lost to newcomers to the vaccine market during the pandemic. -
Wired - Tech
US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. -
Financial Times - World
Frontier emerging markets stocks soar as investors cheer reforms
Argentina’s Merval leads Latin America as heavily indebted nations chart path to growth -
MarketWatch - Business
Paramount stock and bonds snapped up on report deal with Skydance is back on
The deal between Shari Redstone and Skydance Media that was scrapped a few weeks ago has been revived -
MarketWatch - Business
Trump Media to buy assets of WorldConnect Technologies in all-stock deal
Trump Media & Technology Group on Wednesday said it will acquire substantially all of the assets of WorldConnect Technologies.Donald Trump -
MarketWatch - Business
Jeff Bezos aims to sell another $5 billion of Amazon stock, after earlier selling spree
The Amazon founder and executive chair has filed to sell up to 25 million shares, after he dumped 50 million in February. -
CNBC - Business
Saks Fifth Avenue parent HBC to acquire Neiman Marcus Group in $2.65 billion deal
The deal will establish Saks Global, which will include Saks Fifth Avenue, Saks OFF 5TH, Neiman Marcus' namesake department store chain and Bergdorf Goodman. -
MarketWatch - Business
Saks Fifth Avenue buying Neiman Marcus in $2.65 billion deal, with backing by Amazon
High-end retail chains Saks Fifth Avenue will buy rival Neiman Marcus in a deal that will see Amazon.com and Salesforce also take stakes, the companies said in a statement on Thursday. -
CBS News - Top stories
Florida sees COVID-19 surge in emergency rooms, near past winter's peaks
The CDC says several states are seeing "consistent increases in COVID-19 activity" this summer.Florida
More from MarketWatch
-
MarketWatch - Business
Is it possible to get a 5% mortgage rate? Yes, but here’s the catch.
Mortgage rates are hovering just below 7%, but there are ways for home buyers to get much lower rates. -
MarketWatch - Business
JPMorgan Chase, Citi and Wells Fargo earnings to follow relative strength in their stocks
U.S.’s largest banks draw investor support as havens from sector headwinds from commercial real estate woes. -
MarketWatch - Business
U.S. presidential election highlights biggest risk to a bond-market rally in the second half
Of all the wild cards in the months ahead for the $27 trillion Treasury market, an increasing U.S. government deficit is regarded as perhaps the greatest long-term risk facing the market right now because of its potential to translate into higher ... -
MarketWatch - Business
‘Any technology stock with an AI story is rising too far and too fast,’ this veteran trader warns
The market is in a huge tech-led bubble — but you’d be wrong to bet against it. -
MarketWatch - Business
Why this fund manager trimmed his Nvidia position — and has a warning about AI
Ken Laudan of Buffalo Funds has changed his opinion about how long it will take for “AI adopters” to make the technology useful.